Turku University Hospital is a hospital in Turku, Finland.

There are 900 beds in Turku University Hospital.

During the past decade, Turku University Hospital conducted 193 clinical trials. In the 10-year time frame, 193 clinical trials started and 33 clinical trials were completed, i.e. on average, 17.1% percent of trials that started reached the finish line to date. In the past 5 years, 86 clinical trials started and 17 clinical trials were completed. i.e. 19.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Turku University Hospital" #1 sponsor was "Turku University Hospital" with 107 trials, followed by "University of Turku" with 20 trials sponsored, "Helsinki University Central Hospital" with 11 trials sponsored, "University of Oulu" with 10 trials sponsored and "Celgene" with 10 trials sponsored. Other sponsors include 162 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Turku University Hospital" #1 collaborator was "Turku University Hospital" with 39 trials as a collaborator, "Helsinki University Central Hospital" with 32 trials as a collaborator, "Oulu University Hospital" with 30 trials as a collaborator, "Tampere University Hospital" with 28 trials as a collaborator and "Kuopio University Hospital" with 27 trials as a collaborator. Other collaborators include 386 different institutions and companies that were collaborators in the rest 257 trials.

According to Clinical.Site data, the most researched conditions in "Turku University Hospital" are "Prostate Cancer" (12 trials), "Coronary Artery Disease" (10 trials), "Atrial Fibrillation" (8 trials), "Multiple Myeloma" (6 trials) and "Stroke" (6 trials). Many other conditions were trialed in "Turku University Hospital" in a lesser frequency.

Most popular intervention types in "Turku University Hospital" are "Drug" (143 trials), "Device" (51 trials), "Procedure" (50 trials), "Other" (47 trials) and "Biological" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Dexamethasone" (5 trials), "placebo" (4 trials), "Bortezomib" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Turku University Hospital" are 271 trials for "All" genders, 28 trials for "Female" genders and 25 trials for "Male" genders.

Currently, there are 122 active trials in "Turku University Hospital". 5 are not yet recruiting, 70 are recruiting, 41 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 137 completed trials in Turku University Hospital, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Turku University Hospital, 14 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 106 trials that are defined as “Not Applicable".